Dogwood Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Dogwood Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Dogwood Therapeutics Inc.
Rating: 1.31000
Author: Trendlyne DVM scores

about

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibro...

4.90 -0.10 (-2.00%)

83.27% Fall from 52W High

5,703

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

52.4 / 100

No estimates available

Dogwood Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dogwood Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibro...

83.27% Fall from 52W High

SWOT Analysis

Dogwood Therapeutics Inc. Live Price Chart